AAMI Foundation Institute to Conduct First Infusion Safety Study

June 04, 2012
June 4, 2012

Earlier this week, the Association for the Advancement of Medical Instrumentation (AAMI) Foundation announced that its Healthcare Technology Safety Institute (HTSI) has been granted $328,660 from CareFusion Foundation to conduct a study on IV medication and smart pumps, specifically on patient safety.

The three-year study will revolve around key issues concerning the administration of intravenous (IV) medication delivery via Smart pumps. To be carried out by Brigham and Women’s Hospital (BWH) in Boston, the study will identify and evaluate the errors in IV medication and determine how these can be prevented.

According to the institute, the study will kick off from AAMI’s previous work with the US Food and Drug Administration (FDA) back in 2010. The past project resulted into a summit hosted by the two institutions and the subsequent drafting of the 13 priorities for improving infusion safety.

"IV medication errors represent one of the most significant safety and cost threats for hospitals, and studies have shown that many of these errors are preventable," said Tim Vanderveen, PharmD, vice president of The Center for Safety and Clinical Excellence at CareFusion and a member of the AAMI board of directors. "The adoption of smart IV pumps has yielded a treasure trove of new information that has helped us understand the high degree of variability in the IV medication process. This study will deliver even more insight to drive best practices in IV therapy and help clinicians better leverage technology to avoid errors and improve patient care."

AAMI President Mary Logan also added that the study will focus on patient safety, upholding HTSI’s main goal. The research project will start in fall, analyzing ten hospitals across the US. Evaluations will be conducted by BWH and the facility’s research arm, Division of Internal General Medicine and Primary Care. The two will look for any irregularities with the medication orders and actual medication administration. The following years will look into the data, and develop solutions and improvements for safe drug infusion, preventing, if not eliminating medication errors. These proposed solutions will be implemented and observed. At the final phase of the project, the research team will publish their final conclusion of study.

Together with carefully administered drug infusion, a properly serviced infusion pump system should be used to prevent any medication errors. AIV supports most leading infusion pumps in the market today. For AIV’s full line of replacement parts and repair services, visit http://www.aiv-inc.com/iv-infusion-pump-replacement-parts.html.

About the Author

Laura Collier

Laura Collier

Laura Collier has a Bachelor’s Degree in Communications and a Master’s Degree in Business Administration from the University of North Florida. She is the Marketing Manager at AIV, Inc.

AIV Catalog

Request Your Printed or Electronic Copy Today!
We Respect Your Privacy

Be Part of Our
Biomed Community

Healthcare technology management professionals are a vital link in hospital operations, and we proudly support the national, state, and local associations with ongoing support and resources.

Get Biomed Resources

Why buy from AIV

AIV strives to provide you cost effective options to service equipment. We offer flexible solutions to best suit your needs.